Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT05486104 |
| Consolidated Lead Sponsor | Ganzhou Hemay Pharmaceutical Co |
| Therapeutic Condition Cohort | Immunology, Rheumatology, and Dermatology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | ACTIVE NOT RECRUITING |
| Registered Enrollment | 92 participants (ACTUAL) |
| Registered Start Date | 2022-11-08 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| The First Affiliated Hospital Of Fujian Medical University | Fuzhou, China | Open Hospital Dossier -> |
| The Second Affiliated Hospital of Guangzhou Medical University | Guangzhou, China | Open Hospital Dossier -> |
| Xiangya Hospital of Central South University | Changsha, China | Open Hospital Dossier -> |
| The First Affiliated Hospital of Nanchang University | Nanchang, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Immunology, Rheumatology, and Dermatology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.